{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:01:19Z","timestamp":1789002079803,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmg.2025.105062","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:04:02Z","timestamp":1763658242000},"page":"105062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["French recommendations on multi-gene panel testing in renal cell carcinoma"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2350-3906","authenticated-orcid":false,"given":"Sophie","family":"Giraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Abadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Benusiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bonadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Coupier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Crivelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Delnatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Devulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"DE Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dussart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lejeune-Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Tinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nogues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Burnichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejmg.2025.105062_bib1","article-title":"Trans-ethnic variation in germline variants of patients with renal cell carcinoma","volume":"34","author":"Abou","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmg.2025.105062_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cancergen.2021.07.003","article-title":"Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumors","volume":"258\u2013259","author":"Adolphe","year":"2021","journal-title":"Cancer Genet."},{"issue":"7","key":"10.1016\/j.ejmg.2025.105062_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"16","key":"10.1016\/j.ejmg.2025.105062_bib4","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/hmg\/ddac066","article-title":"Elongin C (ELOC\/TCEB1)-associated von Hippel-Lindau disease","volume":"31","author":"Andreou","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib6","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1210\/clinem\/dgaa741","article-title":"Genotype-phenotype features of germline variants of the TMEM127 pheochromocytoma susceptibility gene: a 10-Year update","volume":"106","author":"Armaiz-Pena","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ejmg.2025.105062_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100194","article-title":"Biallelic ELOC-inactivated renal cell carcinoma: molecular features supporting classification as a distinct entity","volume":"36","author":"Batavia","year":"2023","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A germline mutation in PBRM1 predisposes to renal cell carcinoma","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2025.105062_bib8","first-page":"163","article-title":"Orphanet. Renal cell tumour characteristics in patients with the birt-Hogg-Dub\u00e9 cancer susceptibility syndrome: a retrospective, multicentre study","volume":"9","author":"Benusiglio","year":"2014","journal-title":"J Rare Dis."},{"issue":"7375","key":"10.1016\/j.ejmg.2025.105062_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmg.2025.105062_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2016.173","article-title":"Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (VHL) in Denmark","volume":"25","author":"Binderup","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0198","article-title":"SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?","volume":"30","author":"Branzoli","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"issue":"21","key":"10.1016\/j.ejmg.2025.105062_bib13","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1002\/cncr.33679","article-title":"Genetic risk assessment for hereditary renal cell carcinoma: clinical consensus statement","volume":"127","author":"Bratslavsky","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib14","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jmg-2022-109104","article-title":"Update of penetrance estimates in Birt-Hogg-Dub\u00e9 syndrome","volume":"60","author":"Bruinsma","year":"2023","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien","year":"2013","journal-title":"J. Med. Genet."},{"issue":"10","key":"10.1016\/j.ejmg.2025.105062_bib17","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejmg.2025.105062_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.ejmg.2025.105062_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib21","article-title":"Metabolic reprogramming in renal cancer: events of a metabolic disease","volume":"1876","author":"Chakraborty","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"8","key":"10.1016\/j.ejmg.2025.105062_bib22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/cancers11081114","article-title":"Families with BAP1-Tumor predisposition syndrome in the Netherlands: path to identification and a proposal for genetic screening guidelines","volume":"11","author":"Chau","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JU.0000000000004089","article-title":"Germline pathogenic variants identified in patients with genitourinary malignancies undergoing universal testing: a multisite single-institution prospective study","volume":"212","author":"Choudry","year":"2024","journal-title":"J. Urol."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib24","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"de Andrade","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmg.2025.105062_bib25","series-title":"Saint Maurice (Fra)","article-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. Volume 1 \u2013 tumeurs solides","author":"Defossez","year":"2019"},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2020.104080","article-title":"National recommendations of the French genetics and cancer group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract","volume":"63","author":"Dhooge","year":"2020","journal-title":"Eur. J. Med. Genet."},{"issue":"23","key":"10.1016\/j.ejmg.2025.105062_bib27","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","article-title":"Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals","volume":"3","author":"Forde","year":"2020","journal-title":"Eur. Urol. Oncol."},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cge.12807","article-title":"Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with birt-Hogg-Dub\u00e9 syndrome","volume":"90","author":"Furuya","year":"2016","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6603492","article-title":"Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma","volume":"96","author":"Gad","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ejmg.2025.105062_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1012357","article-title":"Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4","volume":"364","author":"Gill","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib32","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1038\/s41467-020-17304-3","article-title":"Global translation during early development depends on the essential transcription factor PRDM10","volume":"11","author":"Han","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4132\/jptm.2021.01.26","article-title":"Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene","volume":"55","author":"Han","year":"2021","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jnci\/djac188","article-title":"Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome","volume":"115","author":"Hendricks","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ejmg.2025.105062_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/genes12101585","article-title":"Renal cell carcinoma in Tuberous sclerosis complex","volume":"12","author":"Henske","year":"2021","journal-title":"Genes"},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib38","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/bjc.2011.463","article-title":"Renal cancer and pneumothorax risk in Birt-Hogg-Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families","volume":"105","author":"Houweling","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmg.2025.105062_bib39","article-title":"Comprehensive genomic landscape in Chinese clear cell renal cell carcinoma patients","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ejmg.2025.105062_bib40","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/cancers13092243","article-title":"The PI3K\/mTOR pathway is targeted by rare germline variants in patients with both Melanoma and renal cell carcinoma","volume":"13","author":"Hubert","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/gcc.22338","article-title":"Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells","volume":"55","author":"Hulsebos","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.ejmg.2025.105062_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","article-title":"Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma","volume":"5","author":"Jafri","year":"2015","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib43","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.juro.2011.02.007","article-title":"Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease","volume":"185","author":"Joly","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.ejmg.2025.105062_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737547","article-title":"Germline mutation landscape and associated clinical characteristics in Chinese patients with renal cell carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal Oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264056","article-title":"A retrospective two centre study of Birt-Hogg-Dube syndrome reveals a pathogenic founder mutation in FLCN in the Swedish population","volume":"17","author":"Lagerstedt-Robinson","year":"2022","journal-title":"PLoS One"},{"issue":"12\u201313","key":"10.1016\/j.ejmg.2025.105062_bib47","first-page":"188","article-title":"Incidence des principaux cancers en France m\u00e9tropolitaine en 2023 et tendances depuis 1990","author":"Lap\u00f4tre-Ledoux","year":"2023","journal-title":"Bull \u00c9pid\u00e9miol Hebd"},{"issue":"7\u20138","key":"10.1016\/j.ejmg.2025.105062_bib48","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.5489\/cuaj.3798","article-title":"Structured assessment and followup for patients with hereditary kidney tumour syndromes","volume":"10","author":"Lattouf","year":"2016","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","article-title":"Increased risk of cancer in patients with fumarate hydratase germline mutation","volume":"43","author":"Lehtonen","year":"2006","journal-title":"J. Med. Genet."},{"issue":"11","key":"10.1016\/j.ejmg.2025.105062_bib50","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","volume":"22","author":"Linehan","year":"2012","journal-title":"Genome Res."},{"issue":"9374","key":"10.1016\/j.ejmg.2025.105062_bib52","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/cen.14289","article-title":"A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: beyond phaeochromocytoma and paraganglioma","volume":"93","author":"MacFarlane","year":"2020","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib54","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","volume":"36","author":"Maher","year":"2018","journal-title":"World J. Urol."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.27.5.311","article-title":"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma","volume":"27","author":"Maher","year":"1990","journal-title":"J. Med. Genet."},{"issue":"283","key":"10.1016\/j.ejmg.2025.105062_bib55","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q. J. Med."},{"issue":"11","key":"10.1016\/j.ejmg.2025.105062_bib58","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","article-title":"PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels","volume":"51","author":"Martin","year":"2019","journal-title":"Nat. Genet."},{"issue":"24","key":"10.1016\/j.ejmg.2025.105062_bib59","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1002\/cncr.25562","article-title":"Characteristics of the coexistence of melanoma and renal cell carcinoma","volume":"116","author":"Maubec","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib60","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam. Cancer"},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib61","doi-asserted-by":"crossref","first-page":"1187.e1","DOI":"10.1016\/j.urology.2011.12.025","article-title":"Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome","volume":"79","author":"Mester","year":"2012","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib62","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and Male genital organs-part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.ejmg.2025.105062_bib63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","volume":"105","author":"Moretta","year":"2018","journal-title":"Bull. Cancer"},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib64","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cge.13014","volume":"92","author":"Muller","year":"2017","journal-title":"Clin. Genet."},{"issue":"17","key":"10.1016\/j.ejmg.2025.105062_bib65","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.2013.53.6656","article-title":"Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations","volume":"32","author":"Ngeow","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.ejmg.2025.105062_bib66","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1002\/cncr.30893","article-title":"Advances in the diagnosis of hereditary kidney cancer: initial results of a multigene panel test","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome","volume":"13","author":"Nieuwenhuis","year":"2014","journal-title":"Fam. Cancer"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13053-021-00189-8","article-title":"Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature","volume":"19","author":"Oliveira","year":"2021","journal-title":"Hered. Cancer Clin. Pract."},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib71","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and management of renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.ejmg.2025.105062_bib72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib73","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2025.105062_bib74","series-title":"H\u00f4pital Cochin","article-title":"Centres de R\u00e9f\u00e9rence des maladies rares des surr\u00e9nales","year":"2021"},{"key":"10.1016\/j.ejmg.2025.105062_bib75","series-title":"Centres De R\u00e9f\u00e9rence Des Epilepsies Rares Du CHU De Lille Et De Necker Enfants Malades","year":"2021"},{"issue":"9","key":"10.1016\/j.ejmg.2025.105062_bib76","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/hmg\/ddt638","article-title":"The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function","volume":"23","author":"Qin","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2025.105062_bib77","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/hmg\/ddi057","article-title":"Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas","volume":"14","author":"Rebouissou","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome Atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmg.2025.105062_bib79","doi-asserted-by":"crossref","first-page":"ddaf173","DOI":"10.1093\/hmg\/ddaf173","article-title":"Tuberous sclerosis complex-associated renal cell carcinoma, an underappreciated form of familial renal cancer, is characterized by activation of the TFEB\/TFE3 pathway","volume":"11","author":"Ricketts","year":"2025","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1897-4287-8-6","article-title":"Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients","volume":"8","author":"Riegert-Johnson","year":"2010","journal-title":"Hered. Cancer Clin. Pract."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-022-02277-x","article-title":"Prevalence of thoracoabdominal imaging findings in Tuberous sclerosis complex","volume":"17","author":"Ritter","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209504","article-title":"Kidney cancer characteristics and genotype-phenotype-correlations in Birt-Hogg-Dub\u00e9 syndrome","volume":"13","author":"Sattler","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13023-021-01917-y","article-title":"Rare manifestations and malignancies in Tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)","volume":"16","author":"Sauter","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.ejmg.2025.105062_bib86","first-page":"1719","article-title":"Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res."},{"issue":"4 Pt 1","key":"10.1016\/j.ejmg.2025.105062_bib87","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib88","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2025.105062_bib89","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/humu.24313","article-title":"Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I","volume":"43","author":"Sebai","year":"2022","journal-title":"Hum. Mutat."},{"issue":"16","key":"10.1016\/j.ejmg.2025.105062_bib90","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1002\/cncr.32914","article-title":"Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer","volume":"126","author":"Shuch","year":"2020","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/gcc.22833","article-title":"Characterization of renal cell carcinoma\u2010associated constitutional chromosome abnormalities by genome sequencing","volume":"59","author":"Smith","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib93","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib94","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/iju.13094","article-title":"Renal cell cancer linked to Lynch syndrome: increased incidence and loss of mismatch repair protein expression","volume":"23","author":"Therkildsen","year":"2016","journal-title":"Int. J. Urol."},{"issue":"10","key":"10.1016\/j.ejmg.2025.105062_bib95","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41431-020-0651-7","article-title":"Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome","volume":"28","author":"Tischkowitz","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib96","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib97","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2025.105062_bib98","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.euo.2021.09.005","article-title":"Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing","volume":"4","author":"Truong","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"7","key":"10.1016\/j.ejmg.2025.105062_bib99","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/hmg\/ddac288","article-title":"PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dube syndrome and familial lipomatosis","volume":"32","author":"van de Beek","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib100","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-Related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ejmg.2025.105062_bib101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"7331","key":"10.1016\/j.ejmg.2025.105062_bib102","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmg.2025.105062_bib103","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.annpat.2020.02.022","article-title":"[Hereditary kidney cancers: the pathologist's view in 2020]","volume":"40","author":"Verkarre","year":"2020","journal-title":"Ann. Pathol."},{"issue":"12","key":"10.1016\/j.ejmg.2025.105062_bib104","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive Study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ejmg.2025.105062_bib105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/cncr.31908","article-title":"Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease","volume":"125","author":"Wu","year":"2019","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.ejmg.2025.105062_bib106","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","article-title":"Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases","volume":"31","author":"Yngvadottir","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.ejmg.2025.105062_bib107","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/thorax-2024-221738","article-title":"Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dub\u00e9 syndrome from genomics and population cohorts","volume":"80","author":"Yngvadottir","year":"2025","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ejmg.2025.105062_bib108","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721225000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721225000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:43:29Z","timestamp":1766051009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721225000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"alternative-id":["S1769721225000692"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2025.105062","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French recommendations on multi-gene panel testing in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2025.105062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105062"}}